Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01729000 · ClinicalTrials.gov registry record · NA

Study to Determine if Gloving in Addition to Hand Hygiene Will Prevent Invasive Infections and Necrotizing Enterocolitis

A NA study of Neonatal Infection and Neonatal Necrotizing Enterocolitis, sponsored by University of Virginia.

Completed
Registry status
NA
Development phase
124
Enrollment target
1
Study location

NCT01729000 is a NA study of Neonatal Infection and Neonatal Necrotizing Enterocolitis that has completed, run by University of Virginia. The registered enrollment target is 124 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01729000, a NA study of Neonatal Infection and Neonatal Necrotizing Enterocolitis, has completed, sponsored by University of Virginia.

COMPLETED
Registry status
NA
Development phase
124 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the additional use of gloves (with handwashing before and after gloving) for all patient contact while infants have intravenous (central or peripheral) access in a RCT. Preterm infants \<1000 grams or less than 29 weeks gestational age will be randomized after birth to either a handwashing-gloving group or handwashing only group. The primary outcome will be the incidence of invasive infections (bacterial or fungal) or necrotizing enterocolitis. Secondary outcomes will include hospital days, preterm morbidities, mortality, and hospital costs.

Interventions

  • OTHER Gloves

Study Locations (1)

Virginia

  • University of Virginia, Newborn Intensive Care Unit - Charlottesville

Trial Details

FieldValue
Enrollment Target 124 participants
Start Date 2008-10
Est. Completion 2011-06
Phase NA

Sponsor

University of Virginia

449 total trials

What the Registry Record Tells You About NCT01729000

The ClinicalTrials.gov registry entry for NCT01729000 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Neonatal Infection appearing as the primary indexed condition, and to 1 intervention - of which Gloves is the first listed.

NCT01729000 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT01729000 about?

NCT01729000 is a clinical study titled "Study to Determine if Gloving in Addition to Hand Hygiene Will Prevent Invasive Infections and Necrotizing Enterocolitis". The purpose of this study is to compare the additional use of gloves (with handwashing before and after gloving) for all patient contact while infants have intravenous (central or peripheral) access in a RCT. Preterm infants \<1000 grams or less than 29 weeks gestational age will be randomized after...

What is the current status of trial NCT01729000?

This trial is currently completed. It is a NA study. The enrollment target is 124 participants. The study started on 2008-10. Estimated completion is 2011-06.

What conditions does trial NCT01729000 study?

This clinical trial studies the following conditions: Neonatal Infection, Neonatal Necrotizing Enterocolitis.

What interventions are being tested in trial NCT01729000?

The interventions under investigation include: Gloves (OTHER).

Who is sponsoring clinical trial NCT01729000?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01729000 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Neonatal Infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.